fosinopril has been researched along with Alloxan Diabetes in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Han, Y; Li, Y; Sun, P; Xu, N | 1 |
| Dong, X; Gong, Y; Gu, Y; Li, P; Lu, X; Sun, S; Wang, H; Yan, M; Zhang, H; Zhang, W; Zhao, T | 1 |
| Araiza-Saldaña, CI; Castañeda-Corral, G; Granados-Soto, V; Hong-Chong, E; Pedraza-Priego, EF; Rocha-González, HI; Torres-López, JE | 1 |
| Cui, W; Hu, L; Huang, H; Lin, J; Xu, W; Zhu, X | 1 |
| Lan, H; Li, P; Liang, Q; Lu, J; Luo, G; Wang, Y; Yin, T; Zhang, H; Zhang, X; Zhao, T | 1 |
| Abdel-Salam, OM; Arbid, MS; el-Batran, SA; el-Shenawy, SM; Nofal, SM | 1 |
| Gu, Y; Lin, S; Ma, J; Zhang, L | 1 |
| Hoenack, C; Roesen, P | 1 |
| Rösen, P; Rösen, R; Rump, AF | 1 |
| Dhein, S; Hilgers, RD; Olbrich, A; Rosen, P | 1 |
| Anderson, S; Brenner, BM; Rennke, HG | 1 |
11 other study(ies) available for fosinopril and Alloxan Diabetes
| Article | Year |
|---|---|
Destruction of the blood-retina barrier in diabetic retinopathy depends on angiotensin-converting enzyme-mediated TGF-β1/Smad signaling pathway activation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cells, Cultured; Coculture Techniques; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Ependymoglial Cells; Fosinopril; Male; Peptidyl-Dipeptidase A; Pyrazoles; Pyrroles; Rats; Rats, Sprague-Dawley; Retina; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1 | 2020 |
Attenuation of diabetic nephropathy by Chaihuang-Yishen granule through anti-inflammatory mechanism in streptozotocin-induced rat model of diabetics.
Topics: Animals; Anti-Inflammatory Agents; Blood Glucose; Chemokine CCL2; Diabetes Mellitus, Experimental; Drug Administration Schedule; Drugs, Chinese Herbal; Fosinopril; Gene Expression Regulation; Hypoglycemic Agents; Kidney; Male; Molecular Structure; Rats; Rats, Wistar; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2014 |
Fosinopril Prevents the Development of Tactile Allodynia in a Streptozotocin-Induced Diabetic Rat Model.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Fosinopril; Hemodynamics; Hyperalgesia; Hyperglycemia; Insulin; Male; Rats; Rats, Wistar; Weight Loss | 2015 |
Effect of fosinopril on chemerin and VEGF expression in diabetic nephropathy rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Chemokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Fosinopril; Intercellular Signaling Peptides and Proteins; Kidney; Male; Rats; Vascular Endothelial Growth Factor A | 2015 |
Intrarenal metabolomics reveals the association of local organic toxins with the progression of diabetic kidney disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Fosinopril; Gas Chromatography-Mass Spectrometry; Humans; Hypertrophy; Kidney Cortex; Male; Metabolomics; Proteinuria; Rats; Rats, Wistar; Toxins, Biological | 2012 |
Studies on the glycemic and lipidemic effect of monopril and losartan in normal and diabetic rats.
Topics: Alloxan; Animals; Blood Glucose; Blood Proteins; Carbamates; Cholesterol, LDL; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Therapy, Combination; Egypt; Fosinopril; Gliclazide; Hyperlipidemias; Hypolipidemic Agents; Lipids; Losartan; Male; Piperidines; Rats; Rats, Sprague-Dawley; Triglycerides | 2004 |
Effects of blocking the renin-angiotensin system on expression and translocation of protein kinase C isoforms in the kidney of diabetic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Transport; Biphenyl Compounds; Blotting, Western; Cell Membrane; Cytosol; Diabetes Mellitus, Experimental; Drug Combinations; Fosinopril; Immunohistochemistry; Irbesartan; Kidney; Kidney Cortex; Male; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles; Tissue Distribution | 2006 |
Inhibition of angiotensin type 1 receptor prevents decline of glucose transporter (GLUT4) in diabetic rat heart.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Transport; Biphenyl Compounds; Cell Membrane; Diabetes Mellitus, Experimental; Fosinopril; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 4; Male; Membrane Proteins; Monosaccharide Transport Proteins; Muscle Proteins; Myocardium; Quinolines; Rats; Rats, Wistar | 1996 |
Influence of angiotensin-converting enzyme inhibition by fosinopril on myocardial perfusion in streptozotocin-diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Coronary Circulation; Coronary Vessels; Diabetes Mellitus, Experimental; Fosinopril; Heart; Hemodynamics; Male; Rats; Streptozocin; Vascular Resistance | 1996 |
Fosinopril improves regulation of vascular tone in mesenteric bed of diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelium, Vascular; Fosinopril; Male; Mesenteric Arteries; Perfusion; Rats; Rats, Wistar; Streptozocin; Vasoconstriction; Vasodilation | 1996 |
Nifedipine versus fosinopril in uninephrectomized diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Fosinopril; Hemodynamics; Longitudinal Studies; Nephrectomy; Nifedipine; Proline; Rats; Rats, Inbred Strains; Renal Circulation | 1992 |